Armenia vs Georgia: Tuberculosis patients living with HIV receiving antiretroviral therapy
Armenia
62 patients
in 2019
Georgia
43 patients
in 2021
Armenia rank
86th
Georgia rank
89th
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Armenia
- Georgia
How they compare
Armenia currently reports 62 patients against 43 patients in Georgia, a difference of 19 patients.
That makes Armenia's figure about 1.4 times Georgia's.
The two have swapped places 5 times across 16 shared years of data; in 2004 it was Georgia ahead.
Armenia ranks 86th and Georgia ranks 89th of 183 countries.
Across the 2 decades both report, Armenia averaged higher in 1 and Georgia in 1.
Head to head by decade
| Decade | Armenia | Georgia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4 patients | 14.5 patients | 10.5 patients | Georgia |
| 2010s | 54.5 patients | 45.1 patients | 9.4 patients | Armenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Armenia or Georgia?
- Armenia, at 62 patients against 43 patients in Georgia as of 2019.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Armenia and Georgia?
- 19 patients, with Armenia ahead.
- How many years of comparable data are there for Armenia and Georgia?
- 16 years are reported by both, from 2004 to 2019.
- How do Armenia and Georgia rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Armenia ranks 86th and Georgia ranks 89th of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.